Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Pharming Group N.V.

Pharming announces public cash offer to the shareholders of Abliva AB
From Pharming Group N.V.
Via GlobeNewswire
Pharming announces positive topline data in pediatric clinical trial of leniolisib
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group to participate in November investor conference
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group reports third quarter 2024 financial results and provides business update
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group to report third quarter 2024 financial results on October 24
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation
From Pharming Group N.V.
Via GlobeNewswire
Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group to participate in September investor conferences
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group reports second quarter and first half 2024 financial results and provides business update
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group to report second quarter and first half 2024 financial results on August 1
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group to participate in June investor conferences
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group to participate in May investor conference
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group reports first quarter 2024 financial results and provides business update
From Pharming Group N.V.
Via GlobeNewswire
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
From Pharming Group N.V.
Via GlobeNewswire
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group to participate in April investor conferences
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group reports fourth quarter and full year 2023 financial results
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group to report fourth quarter and full year 2023 financial results on March 14
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group to participate in February investor conferences
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)
From Pharming Group N.V.
Via GlobeNewswire
Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group to participate in November investor conferences
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group reports third quarter 2023 financial results
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group to report third quarter 2023 financial results on October 26
From Pharming Group N.V.
Via GlobeNewswire
Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
From Pharming Group N.V.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.